-
The WD40 domain is required for LRRK2 neurotoxicity.
PLoS One. 2009 Dec 24;4(12):e8463
PMID: 20041156
-
A comparative study of Lrrk2 function in primary neuronal cultures.
Parkinsonism Relat Disord. 2010 Dec;16(10):650-5
PMID: 20850369
-
Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis.
Cell Death Differ. 2006 Oct;13(10):1641-50
PMID: 16410793
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
Nat Med. 2010 Sep;16(9):998-1000
PMID: 20729864
-
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
J Neurochem. 2008 May;105(3):1048-56
PMID: 18182054
-
An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways.
J Biol Chem. 2000 Sep 8;275(36):27823-31
PMID: 10880512
-
Clinical progression in Parkinson disease and the neurobiology of axons.
Ann Neurol. 2010 Jun;67(6):715-25
PMID: 20517933
-
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?
J Neurochem. 2009 Sep;110(5):1514-22
PMID: 19545277
-
Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase.
EMBO J. 2008 Aug 20;27(16):2239-49
PMID: 18650931
-
Transform-based backprojection for volume reconstruction of large format electron microscope tilt series.
J Struct Biol. 2006 May;154(2):144-67
PMID: 16542854
-
The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.
J Neurosci Res. 2008 Jun;86(8):1711-20
PMID: 18214993
-
Kinase activity of mutant LRRK2 mediates neuronal toxicity.
Nat Neurosci. 2006 Oct;9(10):1231-3
PMID: 16980962
-
Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis.
J Cell Biol. 1998 Jun 1;141(5):1243-53
PMID: 9606215
-
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.
J Biol Chem. 2008 Jun 13;283(24):16906-14
PMID: 18397888
-
The familial Parkinsonism gene LRRK2 regulates neurite process morphology.
Neuron. 2006 Nov 22;52(4):587-93
PMID: 17114044
-
Genome-wide association study reveals genetic risk underlying Parkinson's disease.
Nat Genet. 2009 Dec;41(12):1308-12
PMID: 19915575
-
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
Hum Mol Genet. 2009 Nov 1;18(21):4022-34
PMID: 19640926
-
Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8.
J Cell Sci. 2002 Jul 1;115(Pt 13):2757-70
PMID: 12077366
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron. 2004 Nov 18;44(4):601-7
PMID: 15541309
-
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1499-504
PMID: 18230735
-
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization.
Biochem J. 2010 Sep 15;430(3):405-13
PMID: 20659021
-
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.
Nat Genet. 2009 Dec;41(12):1303-7
PMID: 19915576
-
LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.
Neurochem Res. 2007 Oct;32(10):1700-8
PMID: 17440812
-
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
Nat Rev Neurosci. 2010 Dec;11(12):791-7
PMID: 21088684
-
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.
Parkinsonism Relat Disord. 1997 Nov;3(3):125-39
PMID: 18591067
-
Axonal dynactin p150Glued transports caspase-8 to drive retrograde olfactory receptor neuron apoptosis.
J Neurosci. 2005 Jun 29;25(26):6092-104
PMID: 15987939
-
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
Hum Mol Genet. 2007 Jan 15;16(2):223-32
PMID: 17200152
-
LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.
J Neurosci. 2010 Sep 29;30(39):13138-49
PMID: 20881132
-
Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation.
J Cell Biol. 2000 Mar 20;148(6):1131-40
PMID: 10725326
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
Neurobiol Dis. 2006 Aug;23(2):329-41
PMID: 16750377
-
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis.
J Neurosci. 2009 Nov 4;29(44):13971-80
PMID: 19890007
-
The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.
J Neurosci. 2009 Jan 28;29(4):1011-6
PMID: 19176810
-
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.
Biochem J. 2007 Jul 15;405(2):307-17
PMID: 17447891